XDEEO
LIVE

Serial Number

99155750

Owner

Longboard Pharmaceuticals, Inc.

Attorney

Maren Perry

Filing Date

Apr 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

XDEEO Trademark

Serial Number: 99155750

XDEEO is a trademark filed by Longboard Pharmaceuticals, Inc. on April 25, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Longboard Pharmaceuticals, Inc.

4275 Executive Square
La Jolla, CA 92037

Entity Type: 03

Trademark Details

Filing Date

April 25, 2025

Registration Date

Not Registered

Published for Opposition

February 10, 2026

Goods & Services

Sanitary preparations for medical purposes; dietetic preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases of, generated from or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the diagnosis, prevention and/or treatment of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances for diagnosis, prevention and treatment of dementia, Alzheimer's disease, depression, psychosis, anxiety, Lennox-Gastaut disease, epilepsy, Dravet Syndrome, Developmental and Epileptic Encephalopathy (DEE), alpha-synucleinopathies, Multiple System Atrophy (MSA), dementia with Lewy bodies, sleep behavior syndrome, porphyria, Huntington's disease, insomnia, Parkinson's disease, sclerosis, multiple sclerosis, schizophrenia, bipolar disorder, cancer, pain, migraine, headache, Horton's headache, traumatic brain injury, post-traumatic brain injury, dizziness, seizures, stroke, cognitive impairment, cognitive disorders and diseases, mood disorders, falls, movement disorders and diseases, tremor, agitation, mania, aggression, autism, melancholia, Tourette's syndrome, restlessness, akathisia, fatigue, somnolence, nausea, Cushing's disease, Adrenogenital syndrome (AGS), narcolepsy, Thyroid Associated Orbitopathy (TAO), Graves Orbitopathy, Hashimoto's Thyroiditis, alcoholism and addiction

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 7, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 17, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 17, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 17, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 17, 2026 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 18, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 18, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 18, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 17, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 25, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 25, 2025 NWOS
NEW APPLICATION ENTERED
Apr 25, 2025 NWAP